- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT03185507
The Effect of Cryotherapy on Cerebral Hemodynamics Within Healthy Subjects
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
The prevalence of concussion has been estimated to be between 4,380 and 10,403 concussions per day in the United States annually with over an estimated 3 million visits to emergency departments each year.1 Symptoms following a concussion last up to 10 days for 90% of cases2; however, the reduction of symptoms in this time frame does not indicate full neurometabolic recovery.
Following concussion, a neurometabolic cascade of events immediately occurs following initial impact with return to normative values around 30 days post-injury. In an attempt to maintain homeostasis in the brain following impact, glucose and oxygen demand increases temporarily and are coupled with periods of increased hyperperfusion and decreased cerebral blood flow (CBF). Although the neurometabolic timeline immediately following impact is only generally understood, there is consensus upon acute increases in CBF and metabolic activity followed by decreased CBF until return to normative values.
Cryotherapy has been studied extensively for its' effects throughout the musculoskeletal system. Cryotherapy in the musculoskeletal system has been shown to decrease tissue temperature and blood flow, as well as decrease oxygen and energy demands.12-19 Cryotherapy has also been applied in cases of moderate or severe traumatic brain injury and has demonstrated to decrease intracranial metabolic processes and oxygenation consumption. Although the potential benefits of cryotherapy have been established in cases of moderate to severe traumatic brain injury (TBI), there is no current research examining cryotherapy in the treatment of concussion.
A convenience sample of 34 healthy, recreationally active individuals between the ages of 18-25 years will be recruited for participation in this study. The independent variable in this study will be group (cryotherapy, control). The primary outcome measures of interest are cognitive functioning measured using the Stroop Test and cerebral blood hemodynamics and hemoglobin saturation measured using near infrared spectroscopy. The pain visual analog scale (VAS) will be used to quantify tolerance to the intervention.
The following study will address the following objectives and related hypotheses:
Objective 1: To determine if the application of cryotherapy influences intracranial hemodynamics within healthy recreationally active young adults.
Hypothesis 1: Cryotherapy will cause a decrease in intracranial hemodynamics; specifically, the CO2 saturation and deoxygenated hemoglobin causing a decrease in intracranial metabolic activity.
Objective 2: To determine if the application of cryotherapy decreases cerebral blood flow within healthy recreationally active individuals.
Hypothesis 2: The application of cryotherapy will not cause a change in cerebral blood flow due to the highly regulated central nervous system.
Studietype
Inschrijving (Werkelijk)
Fase
- Fase 1
Contacten en locaties
Studie Locaties
-
-
Virginia
-
Charlottesville, Virginia, Verenigde Staten, 22904
- University of Virginia Memorial Gymnasium
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Between 18 and 25 years of age
- Recreationally active (exercise at least 30 minutes, 3 times weekly)
Exclusion Criteria:
- Contraindications for cryotherapy (eg. Raynaud's phenomenon, cold urticaria)
- Any documented learning difficulty or disability
- Any known neurological or psychiatric disorder
- History of migraines
- History of a concussion or traumatic brain injury in past 6 months
- Currently taking psychotropic medications
- Any known metabolism diseases
- Any known hematological diseases
- Any recreational drug use in past month
- Any known cardiopulmonary impairments or pathologies
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Cryotherapy
Participants received superficial cryotherapy using the Cryohelmet(TM)
|
Cryotherapy was administered using the Catalyst CryoHelmet™ (All-Star Sporting Goods®, Shirley, Massachusetts, USA).
The CyroHelmet is a flexible helmet equipped with gel ice packs meant to cool the head and neck.
|
|
Geen tussenkomst: Control
Participants sat quietly for 20 minutes
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Oxygenated blood
Tijdsspanne: Oxygenated blood was collected throughout the data collection period (45 minutes)
|
Oxygenated blood based on functional near-infrared spectroscopy (fNIRS) data output
|
Oxygenated blood was collected throughout the data collection period (45 minutes)
|
|
Deoxygenated blood
Tijdsspanne: Dexoygenated blood was collected throughout the data collection period (45 minutes)
|
Deoxygenated blood based on functional near-infrared spectroscopy (fNIRS)
|
Dexoygenated blood was collected throughout the data collection period (45 minutes)
|
|
Stroop Task reaction time
Tijdsspanne: Stroop Task reaction time was collected prior to and following the intervention. Each test took approximately 5 minutes to complete.
|
Reaction time measured in milliseconds while completing the Stroop Task
|
Stroop Task reaction time was collected prior to and following the intervention. Each test took approximately 5 minutes to complete.
|
Medewerkers en onderzoekers
Sponsor
Publicaties en nuttige links
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- 19706
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Zuurstoftekort
-
The Hospital for Sick ChildrenBristol-Myers SquibbBeëindigdRefractaire of recidiverende gehypermuteerde maligniteiten | Biallelic Mismatch Repair Deficiency (bMMRD) positieve patiëntenVerenigde Staten, Frankrijk, Canada, Australië, Israël
-
Rutgers, The State University of New JerseyNational Institute of Mental Health (NIMH)WervingHiv | Zelfmoordgedachten en -gedrag | AIDS (Acquired Immune Deficiency Syndrome)Verenigde Staten
-
Columbia UniversityVoltooidHumaan Immunodeficiëntie Virus (HIV) | Verworven Immune Deficiency Syndrome (AIDS)Lesotho
-
Makerere UniversityVaccine and Gene Therapy Institute, FloridaVoltooidVerworven Immune Deficiency Syndrome Virus
-
Guang'anmen Hospital of China Academy of Chinese...OnbekendHIV-infecties | Verworven Immune Deficiency Syndrome VirusChina
-
Gilead SciencesVoltooidHIV-infecties | Verworven Immune Deficiency Syndrome (AIDS)Verenigde Staten, Thailand, Oeganda, Zuid-Afrika, Zimbabwe
-
Keck School of Medicine of USCAIDS Healthcare Foundation; Los Angeles General Medical CenterNog niet aan het wervenAntiretrovirale therapie, zeer actief | HIV (Humaan Immunodeficiëntie Virus) | Gepersonaliseerde geneeskunde | Klinisch beslissingsondersteunend systeem (CDSS) | AIDS (Acquired Immune Deficiency Syndrome) | GEINDIVIDUALISEERDE THERAPIE | PrecisiegeneeskundeVerenigde Staten
-
Gilead SciencesBeëindigdHIV-infecties | Verworven Immune Deficiency Syndrome (AIDS)Verenigde Staten, Thailand, Spanje, Oeganda, Zuid-Afrika, Italië
-
Juan A. ArnaizOnbekendVerworven Immune Deficiency Syndrome VirusSpanje
-
Guang'anmen Hospital of China Academy of Chinese...OnbekendHIV-infecties | Verworven Immune Deficiency Syndrome VirusChina